menu
    • menu

    Company profile for ReAlta Life Sciences

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ReAlta Life Sciences, Inc. is an early-stage biotech company dedicated to harnessing the power of the immune system to address life-threatening medical needs. To support its vision, ReAlta has developed a novel class of drugs with unique multi-modal therapeutic capabilities that rebalance complement and inflammatory processes. The company was incorporated in late 2018, and is located in Norfolk, Virginia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ReAlta Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5665 Lowery Rd Suite 100, Norfolk, VA 23502
    Telephone
    Telephone
    +1 7579010460
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://realtalifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/realta-life-sciences-inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ReAltaLS

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ReAlta Presents Phase 2 Data on Steroid-Refractory GVHD at ASH
    ReAlta Presents Phase 2 Data on Steroid-Refractory GVHD at ASH

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204682621/en/ReAlta-Announces-Promising-Phase-2-Data-Demonstrating-Rapid-Clinical-Responses-and-Target-Engagement-in-Steroid-Refractory-Acute-GvHD-at-the-ASH-2025-Annual-Meeting

    BUSINESSWIRE
    06 Dec 2025
    Share Share
    Realta Pharma Names Dr. Howard Berman Executive Chairman
    Realta Pharma Names Dr. Howard Berman Executive Chairman

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251123520322/en/ReAlta-Life-Sciences-Appoints-Dr.-Howard-Berman-as-Executive-Chairman

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    ReAlta Presents RLS-0071 Data at 2025 ASH Meeting
    ReAlta Presents RLS-0071 Data at 2025 ASH Meeting

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251105906999/en/ReAlta-Life-Sciences-to-Present-RLS-0071-pegtarazimod-Clinical-Data-at-2025-American-Society-of-Hematology-Annual-Meeting

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    ReAlta Gets Orphan Drug Status for RLS-0071 in Graft-Versus-Host
    ReAlta Gets Orphan Drug Status for RLS-0071 in Graft-Versus-Host

    21 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250820235281/en/ReAlta-Life-Sciences-Receives-EMA-Orphan-Drug-Designation-for-RLS-0071-pegtarazimod-for-the-Treatment-of-Graft-Versus-Host-Disease

    BUSINESSWIRE
    21 Aug 2025
    Share Share
    ReAlta Life Appoints Leader Ellen as Chief Business Officer
    ReAlta Life Appoints Leader Ellen as Chief Business Officer

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250725277270/en/ReAlta-Life-Sciences-Strengthens-Management-Team-with-the-Appointment-of-Biotechnology-Business-Leader-Ellen-Lubman-MBA-as-Chief-Business-Officer

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    ReAlta: RLS-0071 Cuts Brain Inflammation in Preclinical Test
    ReAlta: RLS-0071 Cuts Brain Inflammation in Preclinical Test

    22 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250721025686/en/ReAlta-Life-Sciences-Publishes-Data-Demonstrating-RLS-0071-pegtarazimod-Reduces-Brain-Inflammation-in-Preclinical-Hypoxic-Ischemic-Encephalopathy-Model

    BUSINESSWIRE
    22 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search